Form 8-K - Current report:
SEC Accession No. 0001193125-21-308139
Filing Date
2021-10-26
Accepted
2021-10-26 17:24:39
Documents
15
Period of Report
2021-10-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d228268d8k.htm   iXBRL 8-K 29549
2 EX-99.1 d228268dex991.htm EX-99.1 13754
6 GRAPHIC g228268g1026011610965.jpg GRAPHIC 3327
7 GRAPHIC g228268g1026011611231.jpg GRAPHIC 2570
  Complete submission text file 0001193125-21-308139.txt   184037

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bvs-20211026.xsd EX-101.SCH 2862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bvs-20211026_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bvs-20211026_pre.xml EX-101.PRE 11841
8 EXTRACTED XBRL INSTANCE DOCUMENT d228268d8k_htm.xml XML 3472
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 211349701
SIC: 3841 Surgical & Medical Instruments & Apparatus